(19)
(11) EP 2 485 686 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.07.2014 Bulletin 2014/31

(45) Mention of the grant of the patent:
14.05.2014 Bulletin 2014/20

(21) Application number: 10763550.0

(22) Date of filing: 28.09.2010
(51) International Patent Classification (IPC): 
A61F 2/38(2006.01)
(86) International application number:
PCT/US2010/050497
(87) International publication number:
WO 2011/043955 (14.04.2011 Gazette 2011/15)

(54)

TIBIAL IMPLANT BASE

BASIS FÜR TIBIAIMPLANTAT

BASE POUR IMPLANT TIBIAL

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 06.10.2009 US 574009

(43) Date of publication of application:
15.08.2012 Bulletin 2012/33

(73) Proprietor: Wright Medical Technology, Inc.
Arlington, TN 38002-9501 (US)

(72) Inventors:
  • HARTDEGEN, Vernon, R.
    Collierville TN 38017 (US)
  • TUTTLE, David, R.
    Memphis TN 38104 (US)
  • GREEN, John, M. II
    Arlington TN 38002 (US)

(74) Representative: Hirsch & Associés 
58, avenue Marceau
75008 Paris
75008 Paris (FR)


(56) References cited: : 
EP-A1- 0 672 397
EP-A2- 0 809 986
 EP-A1- 2 042 134
US-A1- 2005 055 102
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).